Show simple item record

dc.contributor.authorJoshi, MD
dc.contributor.authorUnger, WW
dc.contributor.authorvan Beelen, AJ
dc.contributor.authorBruijns, SC
dc.contributor.authorLitjens, M
dc.contributor.authorvan Bloois, L
dc.contributor.authorKalay, H
dc.contributor.authorStorm, G
dc.contributor.authorvan Kooyk, Y
dc.date.accessioned2013-07-30T13:52:49Z
dc.date.available2013-07-30T13:52:49Z
dc.date.issued2011
dc.identifier.citationInt J Pharm. 2011 Sep 20;416(2):426-32. doi: 10.1016/j.ijpharm.2011.02.055. Epub 2011 Mar 1.en
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/pubmed/21371544
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/52683
dc.description.abstractDendritic cells (DCs) are key antigen presenting cells that have the unique ability to present antigens on MHC molecules, which can lead to either priming or suppression of T cell mediated immune responses. C-type lectin receptors expressed by DCs are involved in antigen uptake and presentation through recognition of carbohydrate structures on antigens. Here we have explored the feasibility of modification of liposomes with glycans for targeting purposes to boost immune responses. The potential of targeting glycoliposomal constructs to the C-type lectin DC-SIGN on DCs was studied using either PEGylated or non-PEGylated liposomes. Our data demonstrate that formulation of the glycoliposomes as PEGylated negatively affected their potential to target to DCs.en
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleDC-SIGN mediated antigen-targeting using glycan-modified liposomes: formulation considerations.en
dc.typeArticleen
local.publisherFaculty of medicineen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record